Hoeck S, Pringels S, Kellen E, Van Herck K, Martens P, Van Limbergen E, Francart J, Van Hal G
Acta Gastroenterol Belg. 2016 Sep-Dec;79(3):421-428.
Investigation of the first participation rate and follow-up results of the Flemish colorectal cancer screening program.
In 2013 five age cohorts with an even age between 66 and 74 year old (n=243 335) were invited by mail to return a completed iFOBT. Participants who tested positive (≥75ng/ml) were referred to a follow-up colonoscopy.
Participation rate was 48.4% (n=117 774). Overall positivity rate was 10.1%, and 78.1% of those tested positive underwent a colonoscopy. The positive predictive value of colonoscopy for CRC was 8.2%, for advanced adenoma 16.9% and for non-advanced adenoma 36.5%.
Based on the EU-guidelines 35% was expected as participation for a first screening round, thus a participation rate of 48.4% is more than acceptable for a first screening year. The high positivity rate can partly be explained by including only the older ages in the start-up-period and by the first year of mass screening in Flanders. (Acta gastroenterol. belg., 2016, 79, 421-428).
调查弗拉芒地区结直肠癌筛查项目的首次参与率及随访结果。
2013年,通过邮件邀请了5个年龄在66至74岁之间的偶数年龄队列(n = 243335)的人群返还一份已完成的免疫化学粪便潜血试验(iFOBT)。检测呈阳性(≥75ng/ml)的参与者被转介至后续的结肠镜检查。
参与率为48.4%(n = 117774)。总体阳性率为10.1%,且检测呈阳性的参与者中有78.1%接受了结肠镜检查。结肠镜检查对结直肠癌的阳性预测值为8.2%,对高级别腺瘤为16.9%,对非高级别腺瘤为36.5%。
根据欧盟指南,首轮筛查的参与率预期为35%,因此,48.4%的参与率对于首轮筛查年份而言是完全可以接受的。高阳性率部分可归因于在启动阶段仅纳入了较高年龄人群以及弗拉芒地区大规模筛查的第一年。(《比利时胃肠病学学报》,2016年,79卷, 421 - 428页)